Physician

James Clyde Barton, M.D.

According to 2025 Medicare claims, James Barton, M.D. (NPI: 1477645992) practices hematology/oncology in the Birmingham, AL market, with the plurality of this provider's patient population coming from Jefferson, AL. This provider's primary affiliated billing organization is SOUTHERN HEMATOLOGY ONCOLOGY PC (NPI: 1194920447; TIN: 631055248) and primary practice location at 35209-6807.

Barton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 93 traditional Medicare patients, billed 42,215 HCPCS/CPT codes, and received $1,338,086 in Medicare payments. The top billing code was 96365 (Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less). Part D data shows 268 prescription claims across 60 beneficiaries totaling $1,534,706 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 101 claims. Open Payments data shows 51 records totaling $1,161. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $155,722 to $1,534,706. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $10,518 to $3,028.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	247	67,686	$1,431,240
2016	238	63,939	$1,564,008
2017	204	61,673	$1,473,126
2018	186	77,527	$1,432,894
2019	187	56,955	$1,234,493
2020	147	59,147	$1,431,809
2021	136	51,520	$1,355,207
2022	122	59,887	$1,360,689
2023	108	53,914	$1,487,154
2024	93	42,215	$1,338,086

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	76	357	$155,722
2016	77	416	$21,083
2017	70	324	$136,861
2018	74	269	$344,731
2019	72	298	$581,249
2020	60	322	$947,191
2021	54	287	$1,007,337
2022	72	313	$985,491
2023	65	290	$1,591,345
2024	60	268	$1,534,706

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	346	$316,379
2016	N/R	335	$346,337
2017	N/R	226	$173,521
2018	N/R	158	$121,943
2019	N/R	150	$124,390
2020	N/R	160	$129,377
2021	N/R	177	$166,407
2022	N/R	185	$195,289
2023	N/R	120	$138,164
2024	N/R	101	$182,719

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	56	517	$41
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	54	257	$39
96366	Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	56	640	$14
36415	Insertion of needle into vein for collection of blood sample	82	631	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	87	648	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	29	812	$635,296
Venclexta	Venetoclax	36	1,060	$487,333
Hydroxyurea	Hydroxyurea	18	940	$462
Potassium Chloride	Potassium Chloride	13	690	$360
Cefdinir	Cefdinir	11	121	$233

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	38	$179,933
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	31	$2,307
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	32	$478

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$1,161	CSL Behring
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Clyde Barton, M.D.?

Tedicare shows public-source Medicare data for James Clyde Barton, M.D. (NPI 1477645992), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Clyde Barton, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Clyde Barton, M.D.?

James Clyde Barton, M.D. is linked to SOUTHERN HEMATOLOGY ONCOLOGY PC (billing NPI 1194920447) in the available physician profile data.

Does James Clyde Barton, M.D. have Open Payments data?

James Clyde Barton, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.